Journal Article DKFZ-2026-02542

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Systemic Inflammation and Colorectal Cancer: Assessing the Role of Reverse Causality.

 ;  ;  ;  ;

2026
MDPI Basel

Cancers 18(19), 3190 () [10.3390/cancers18193190]
 GO

Abstract: Background/Objectives: Prospective studies have reported associations between systemic inflammatory biomarkers and colorectal cancer (CRC) risk, but whether these reflect a causal role of inflammation or responses to preclinical disease remains uncertain. Methods: Using data from 383,850 UK Biobank participants (aged 40-69 years; recruited 2006-2010), we investigated potential reverse causality by assessing these associations according to time since biomarker assessment. Baseline systemic inflammatory markers, including C-reactive protein (CRP), albumin, and blood cell-derived ratios, were assessed. Multivariable Cox models estimated associations with CRC risk across predefined follow-up intervals. Results: Over a median follow-up of 11.8 years, 4996 participants developed CRC. Inflammatory biomarkers were associated with increased CRC risk, particularly during the early follow-up. Associations weakened substantially or disappeared when early follow-up was excluded. For example, CRP was associated with a 3.03-fold higher CRC risk (highest vs. lowest quartile; 95% CI: 2.06-4.45) within the 0-1-year interval, while no association was observed during the 3-5, 6-8, or >8-year intervals. Across complete follow-up, the association remained statistically significant but much weaker (HR: 1.17; 95% CI: 1.07-1.28). Similar patterns were observed for most other biomarkers, except the platelet-to-neutrophil ratio. Conclusions: Our results suggest that the associations between inflammatory biomarkers and CRC risk may partly reflect reverse causality arising from preclinical disease.

Keyword(s): C-reactive protein ; colorectal cancer ; inflammatory biomarkers ; systemic inflammation

Classification:

Note: #EA:M320#LA:M320#

Contributing Institute(s):
  1. Koordinierungsstelle der Cancer Prevention GS (M320)
  2. Klinische Epidemiologie der Krebsfrüherkennung (C070)
Research Program(s):
  1. 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)

Appears in the scientific report 2026
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2026-10-16, last modified 2026-10-17



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)